January 17, 2025

Patient Care Declines After PE Acquisition

A recent study reveals that patient-reported care experience declined significantly at hospitals acquired by private equity firms, highlighting the potential impact of private equity acquisitions on patient care.

Conexiant

January 17, 2025

FDA Approves KRAS Combo for CRC

The approval is based on results from the CodeBreaK 300 clinical trial, a randomized, open-label study that evaluated the safety and efficacy of combining sotorasib with panitumumab.

Conexiant

January 17, 2025

FDA Approves New Drug for Advanced Breast Cancer

Median progression-free survival was 6.9 months in the Datroway group versus 4.9 months in the chemotherapy group.

Conexiant

January 16, 2025

Bone Density Risks in Cancer Survivors

Discover how cancer treatments, lifestyle factors, and comorbidities contribute to long-term bone mineral density deficits in childhood cancer survivors.

Conexiant

January 15, 2025

Higher Surgeon HRV Linked to Better Outcomes

"These results are illustrative of the complex relationship between physiological stress and performance."

Conexiant

January 15, 2025

Lung Cancer's Paradox: Never-Smokers Outlive Smokers?

New research challenges conventional wisdom as never-smokers with NSCLC present with more advanced disease but achieve median survival of 6.6 years versus 3.9 years in smokers, upending traditional prognostic assumptions.

Conexiant

January 15, 2025

Achalasia: Candida's Role in Cancer Risk

New study links esophageal Candida infection to significant cancer risk increase in achalasia patients.

Conexiant

January 15, 2025

PRKG2: Genetic Link Between SSc and LUAD

PRKG2 expression reveals genetic ties between systemic sclerosis and lung adenocarcinoma.

Conexiant

January 15, 2025

Hydrophobic, Chlorhexidine, vs. Standard PICCs

A randomized trial compares hydrophobic, chlorhexidine, and standard polyurethane peripherally inserted central catheters.

Conexiant